Genomics of Personalized Medicine

(Pre-Meeting Symposium ticket purchase required)

Date/Time: Saturday, October 3, 2020 - 6:30 PM – 9:00 PM
Track: Pre-Meeting Symposium
Room: Sacramento
Log in to Add to My Schedule


Unraveling the genetic etiology of neurological disease provides fundamental insights into the cellular pathways underlying disease pathogenesis. It also facilitates disease modeling, as well as the design and testing of targeted therapeutics. This symposium will illustrate how genomics is paving the way for the field to move towards precision-based treatments. Pediatric neurologists have demonstrated that gene modification of a previously untreatable disease, spinal muscular atrophy, is feasible. Here, we will explore how genomic knowledge may be translated into disease-modifying interventions in other neurologic diseases.

Chair: Conrad Weihl, MD, PhD, Washington University in St. Louis
Co-chairs: Bryan J. Traynor, MD, PhD, NIA, NIH and Tritia Yamasaki, MD, PhD, University of Kentucky


  • To review current genetic understanding of neurologic disease

  • To delineate how genetic knowledge can be leveraged to advance the precision medicine paradigm



CRISPR-Mediated Therapeutics for Duchenne Muscular Dystrophy

Genetic Discovery and Translation in Neuromuscular Diseases


Lecture by Dr. Sonja Scholz

Patient-Customized Antisense Therapies for Rare Neurogenetic Diseases

Towards Primary Prevention of Genetic Prion Disease